NHS Breast Screening Programme Central Return Data Set (KC62)
The NHS Breast Screening Programme Central Return Data Set (KC62) provides information to the NHS Breast Screening Programme from Breast Screening Units on the processes and outcomes of the call and recall system.
Overview
Introduction
The NHS Breast Screening Programme Central Return Data Set (KC62) provides information to the NHS Breast Screening Programme from Breast Screening Units on the processes and outcomes of the call and recall system. Screening Programmes are supported by the UK National Screening Committee.
The information is used:
-
to monitor progress towards achieving the cancer targets
-
to ensure that the NHS Breast Screening Programme is monitored and managed effectively.
The NHS Breast Screening Programme Central Return Data Set (KC62) is analysed by NHS England and also used by the Public Health Research Unit to evaluate the effectiveness of Breast Screening. It is also used by the Regional Breast Screening Quality Assurance Reference Centres as part of the quality assurance process, and enables on-going monitoring of their individual programmes and comparisons within their regions and with England overall.
Collection
The NHS Breast Screening Programme Central Return Data Set (KC62) requires information on women invited for Breast Screening, the outcome of the Breast Screening and further information on each cancer detected. It is completed annually and submitted by the end of the October following the end of the REPORTING PERIOD to which the data relates.
Women are included in the NHS Breast Screening Programme Central Return Data Set (KC62) only if the test date offered or SCREENING TEST DATE was within the review period. All Screening Tests taking place within the REPORTING PERIOD are counted. One woman may not have more than one outcome of cancer in the REPORTING PERIOD. Women who are referred directly for a Screening Test (rather than an invitation as part of a Screening Programme) are also included if the SCREENING TEST DATE is within the REPORTING PERIOD.
Submission
The NHS Breast Screening Programme Central Return Data Set (KC62) is submitted via the Breast Screening Information System.
Parts One to Five of the NHS Breast Screening Programme Central Return Data Set (KC62) should be reported for Tables A to T.
TABLE | DESCRIPTION |
A* |
First invitation for routine screening |
B* |
Routine invitation to previous non-attenders |
C1* |
Return invitation to previous attenders (last screen within 5 years) |
C2 |
Return invitation to previous attenders (last screen more than 5 years) |
D |
Short term recall |
E |
Self/GP referrals of women not previously screened |
F1 |
Self/GP referrals of women previously screened (last screen within 5 years) |
F2 |
Self/GP referrals of women previously screened (last screen more than 5 years previously) |
T |
All invitations and screenings: Sum of Tables A - F2 |
* INVASIVE BREAST CANCER TOTAL OBSERVED, INVASIVE BREAST CANCER TOTAL EXPECTED and STANDARDISED DETECTION RATIO TOTAL are only appropriate for tables A, B and C1.
Specification
Organisation and reporting period
To carry details of the reporting organisation and the reporting period. One occurrence of this group is required. |
|
---|---|
Mandation |
Data Elements |
Part One
Invitations and Outcomes: To carry the details of the outcomes of screening and assessment of all women invited and/or screened.Multiple occurrences of this group are permitted, one for each AGE GROUP reported. |
|
---|---|
Mandation |
Data Elements |
WOMEN LOST TO FOLLOW-UP TOTAL (AFTER TECHNICALLY INADEQUATE SCREENING MAMMOGRAM) |
|
Part Two
Assessment:To carry the details of the outcomes of assessment by the procedures involved for all women assessed as a result of screening. Multiple occurrences of this group are permitted, one for each AGE GROUP reported. |
|
---|---|
Mandation |
Data Elements |
WOMEN WITH CANCER DIAGNOSED WITHOUT CYTOLOGY OR HISTOLOGY TOTAL |
|
OUTCOME OF ASSESSMENT UP TO AND INCLUDING CYTOLOGY AND OR CORE BIOPSY REFERRED FOR OPEN BIOPSY TOTAL |
|
OUTCOME OF ASSESSMENT UP TO AND INCLUDING OPEN BIOPSY NO RESULT OR INADEQUATE RESULT TOTAL |
|
OUTCOME OF ASSESSMENT UP TO AND INCLUDING OPEN BIOPSY RESULT BENIGN OR NORMAL ROUTINE RECALL TOTAL |
|
OUTCOME OF ASSESSMENT UP TO AND INCLUDING OPEN BIOPSY CANCER DIAGNOSED TOTAL |
Part Three
Cancer Diagnosed:To carry the details of the cancers formally diagnosed in women assessed as a result of screening. Only breast cancers should be reported. Multiple occurrences of this group are permitted, one for each AGE GROUP reported. |
|
---|---|
Mandation |
Data Elements |
BREAST CANCER INVASIVE SIZE GREATER THAN OR EQUAL TO 10mm AND LESS THAN 15mm TOTAL |
|
BREAST CANCER INVASIVE SIZE GREATER THAN OR EQUAL TO 15mm AND LESS THAN 20mm TOTAL |
|
BREAST CANCER INVASIVE SIZE GREATER THAN OR EQUAL TO 20mm AND LESS THAN 50mm TOTAL |
|
BREAST CANCER INVASIVE SIZE GREATER THAN OR EQUAL TO 50mm TOTAL |
|
Part Four
Outcome Measures:To carry the details of outcome measures related to NHS Breast Screening Programme (NHSBSP) quality targets.Multiple occurrences of this group are permitted, one for each AGE GROUP reported. |
|
---|---|
Mandation |
Data Elements |
WOMEN INVITED FOR ROUTINE SCREENING WITH TECHNICALLY ADEQUATE RESULT (PERCENTAGE OF INVITED) |
|
REFERRAL RATE FOR BREAST ASSESSMENT (PERCENTAGE OF SCREENED) |
|
NON-INVASIVE OR MICRO-INVASIVE BREAST CANCERS DETECTED (PER 1,000 SCREENED) |
|
INVASIVE BREAST CANCER DETECTION RATE INVASIVE SIZE LESS THAN 10mm (PER 1,000 SCREENED) |
|
INVASIVE BREAST CANCER DETECTION RATE INVASIVE SIZE LESS THAN 15mm (PER 1,000 SCREENED) |
|
REFERRAL RATE FOR CYTOLOGY AND OR CORE BIOPSY (PERCENTAGE OF SCREENED) |
|
SHORT TERM RECALL RATE FOLLOWING ASSESSMENT (PERCENTAGE OF SCREENED) |
|
Part Five
Data Completeness Indicators:To carry the details of the completeness of data recorded on information systems in a variety of key areas. Multiple occurrences of this group are permitted, one for each AGE GROUP reported. |
|
---|---|
Mandation |
Data Elements |
CYTOLOGY AND OR CORE BIOPSY RESULT NOT KNOWN (PERCENTAGE OF REFERRED) |
|
BREAST CANCER INVASIVE STATUS NOT KNOWN (PERCENTAGE OF ALL CANCERS DIAGNOSED) |
|
INVASIVE BREAST CANCER SIZE NOT KNOWN (PERCENTAGE OF INVASIVE BREAST CANCERS) |
|
INVASIVE BREAST CANCER LYMPH NODE STATUS NOT KNOWN (PERCENTAGE OF INVASIVE BREAST CANCERS) |
|
INVASIVE BREAST CANCER GRADE NOT KNOWN (PERCENTAGE OF INVASIVE BREAST CANCERS) |
|
INVASIVE BREAST CANCER SPECIAL TYPE NOT KNOWN (PERCENTAGE OF INVASIVE BREAST CANCERS) |
|
BREAST CANCER GRADE NOT KNOWN (PERCENTAGE OF DUCTAL CARCINOMA IN-SITU) |
Annex
Cancers Detected:To carry the details of each cancer detected by the Screening Service in the review period. Multiple occurrences of this group are permitted, one CANCER per WOMAN detected. |
|
---|---|
Mandation |
Data Elements |
NODAL STATUS OF TUMOUR NUMBER OF POSITIVE LYMPH NODES SAMPLED |
|
NODAL STATUS OF TUMOUR NUMBER OF NEGATIVE LYMPH NODES SAMPLED |
|
High Risk Table U
To carry the details of women invited, screened, assessed and cancers detected in a high risk category.Multiple occurrences of this group are permitted, one for each RISK CATEGORY detected. |
|
---|---|
Mandation |
Data Elements |
BREAST CANCER INVASIVE SIZE GREATER THAN OR EQUAL TO 10mm AND LESS THAN 15mm TOTAL |
|
BREAST CANCER INVASIVE SIZE GREATER THAN OR EQUAL TO 15mm AND LESS THAN 20mm TOTAL |
|
BREAST CANCER INVASIVE SIZE GREATER THAN OR EQUAL TO 20mm AND LESS THAN 50mm TOTAL |
|
High Risk Annex
To carry the details of each cancer detected in women in a high risk category.Multiple occurrences of this group are permitted, one for each WOMAN screened. |
|
---|---|
Mandation |
Data Elements |
NODAL STATUS OF TUMOUR NUMBER OF POSITIVE LYMPH NODES SAMPLED |
|
NODAL STATUS OF TUMOUR NUMBER OF NEGATIVE LYMPH NODES SAMPLED |
|
Also Known As
This data set is also known by these names:
Context | Alias |
---|---|
Short name | Breast Screening (KC62) |